Biotrin International - Company Logo
 
 
parvovirus b19 fifth disease
 
  Welcome to Biotrin
 

Biotrin is a healthcare company that specialises in providing a range of novel and proprietary tests for the clinician and research scientist. Biotrin’s headquarters are in Dublin, Ireland where it conducts its research and development, manufacturing and marketing activities.

In our domestic market we also act as representative for the following companies:
  News
 30 Jun 2009Biotrin Customer Care introduces Online Support form
 1 Mar 2009Biotrin appoint new General Manager
 10 Jul 2008Diasorin S.p.A, Italy purchase Biotrin Group Ltd
 10 Jul 2008Argutus Medical Limited - new spin out company of Biotrin's biomarker business
 21 Feb 2008Epstein-Barr Virus – new Multi-test ELISA now available .....read more
 30 Jan 2008Biotrin to distribute new POC product range in Ireland
 

 

 biomarkers
Infectious Diseases

Biotrin’s lead product range are tests to detect Parvovirus B19, a viral infection that can cause miscarriage in pregnant women. Biotrin is the world leader in Parvovirus B19 testing and the only company to have FDA cleared tests. Other CE marked tests: HHV-6, HHV-8, hMPV, Respiratory viruses and Hantavirus.

RSV SOLO

New Product Launch: Biotrin RSV Solo
New rapid test for the detection of RSV antigens in respriatory samples

  • High sensitivity & specificity
  • Results in 10 Minutes
  • 3 simple steps 



The biomarkers division of Biotrin International has been spun out into an independent company called Argutus Medical Ltd.

Argutus Medical ltd

Please Click Here to access the Argutus Medical website
© 2005 Biotrin International
For further information on Fifth Disease click here
Website Design by Net Affinity

93 The Rise, Mount Merrion, Co. Dublin, Ireland.
Tel: +353 1 283 1166 | Fax: +353 1 283 1232
Email: info@biotrin.ie
For technical support please email: customercare@biotrin.ie
Company No. 422701